Research During the COVID-19 Pandemic
As IWK Health works towards the resumption of onsite services, we are able to move forward plans to expand the current research activities being conducted onsite. We are entering new terrain as we prepare to resume some onsite research activities, including facing the possibility of subsequent waves of COVID‐19.
Canada Research Continuity Emergency Fund (CRCEF)
The Canada Research Continuity Emergency Fund (CRCEF) was announced on May 15, 2020, as part of the Government of Canada's (COVID-19 Economic Response Plan. The temporary program was established to help sustain the research enterprise at Canadian universities and health research institutions affected by the COVID-19 pandemic.
Canada Research Continuity Emergency Fund (CRCEF) (August 31, 2020)
CRCEF Stage 3 – Deadline Nov. 9 (October 26, 2020)
The Canada Research Continuity Emergency Fund (CRCEF) is part of the Government of Canada’s COVID-19 Economic Response Plan. Stage 3 of CRCEF will provide funding for incurred costs associated with maintenance and ramp-up of research activities.
All IWK researchers with active research accounts are encouraged to review account expenses and identify eligible CRCEF Stage 3 costs (see Eligible Costs list below). Research funding may be from government or non-government sources. “(Only direct costs of research that are extraordinary and incremental to those already covered by existing sources of funds and have been incurred between March 15 and November 15, 2020 will be reimbursed, at up to 75%.”Note: “The costs of research personnel can be eligible for partial reimbursement at up to 75% in Stage 3 for the period of August 30, 2020, to November 15, 2020, provided that the costs meet the Stage 3 eligible expenses criteria.”
Stage 3 Eligible Expenses Criteria
Projects with considerable, financial balances at the end of the fiscal year (March 31, 2020) are not eligible (i.e., less than 10% of total budget has been spent).
To be eligible for Stage 3, institutions must meet equity, diversity and inclusion requirements. For CRCEF Stage 3, the highest priority for funding will be for applicants from equity-seeking or underrepresented groups. Other priority groups include applicants who have been personally impacted by the pandemic, applicants who undertake non-traditional or unconventional research, and early career researchers. (There is an opportunity to self-identify on the application form.) Projects that are close to their grant end date will be of lower priority.
For more detailed information on the CRCEF program:
Frequently Asked Questions:
The IWK is participating in the CRCEF through Dalhousie University, more information on the program can be found at:
Conducting Research at IWK Health
IWK Health is a global leader in research, innovation and knowledge sharing that directly improves the health and well-being of women, children and families throughout the Maritimes and across the world. Our practice is rooted in a collaborative model that integrates talented people with new technologies, research, training, and clinical excellence. The IWK’s vibrant research community attracts outstanding leaders including nurses, psychologists, pediatricians, psychiatrists, surgeons, obstetricians and gynecologists, to name a few.Share
Research Site Map
IWK Health Research Services
5850/5980 University Ave
PO Box 9700
Nova Scotia, B3K 6R8
If you have a general question about research, our services, facilities or programs please email us below.
If you are looking for a specific individual from one of our departments or facilities please select the button below to view the research services team (individual contact information is provided here).
If you would like to be added to our mailing list and receive our weekly E-Bulletin let us know. Our E-Bulletin is updated with upcoming educational opportunities and accomplishments. Be part of our research community.